This working paper aims to synthesise existing research and thinking on how antimicrobials are procured and ways to improve the current purchasing system.
We collected publicly available information, interviewed experts, and used our diverse range of expertise to analyse and model the COVID-19 vaccine portfolio in order to generate predictions about the vaccine portfolio's timeline.